Scientists Challenge Efficacy Of Folfiri In A Colorectal Cancer Subtype

Share this content:
Scientists challenge the efficacy of folfiri in a colorectal cancer subtype
Scientists challenge the efficacy of folfiri in a colorectal cancer subtype
The current classification system for colorectal cancer, which is based on genetic expression profiles, cannot be used to predict drug responses to FOLFIRI. This is the conclusion reached by a team from the Spanish National Cancer Research Centre (CNIO), formed by members from the Gastrointestinal Cancer Clinical Research Unit and the Structural Computational Biology Group.
READ FULL ARTICLE From Medical Express
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »